BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28634751)

  • 1. Herpesviral vectors and their application in oncolytic therapy, vaccination, and gene transfer.
    Bailer SM; Funk C; Riedl A; Ruzsics Z
    Virus Genes; 2017 Oct; 53(5):741-748. PubMed ID: 28634751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological therapy with oncolytic herpesvirus.
    Benencia F; Coukos G
    Adv Exp Med Biol; 2008; 622():221-33. PubMed ID: 18546631
    [No Abstract]   [Full Text] [Related]  

  • 3. Utilization of herpesviridae as recombinant viral vectors in vaccine development against animal pathogens.
    Kamel M; El-Sayed A
    Virus Res; 2019 Sep; 270():197648. PubMed ID: 31279828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An intravenous stimulus package for oncolytic virotherapy.
    Vile R; Melcher A
    Mol Ther; 2011 Nov; 19(11):1930-2. PubMed ID: 22051602
    [No Abstract]   [Full Text] [Related]  

  • 5. Oncolytic Viruses: Therapeutics With an Identity Crisis.
    Breitbach CJ; Lichty BD; Bell JC
    EBioMedicine; 2016 Jul; 9():31-36. PubMed ID: 27407036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short nucleotide sequences in herpesviral genomes identical to the human DNA.
    Filatov F; Shargunov A
    J Theor Biol; 2015 May; 372():12-21. PubMed ID: 25728788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Special Issue "Recent Advances in Morbillivirus Vaccine Development and Oncolytic Virotherapy".
    Lin LT
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32245003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the development of oncolytic HSV-1 vectors: 'arming' of HSV-1 vectors and application of bacterial artificial chromosome technology for their construction.
    Jeyaretna DS; Kuroda T
    Curr Opin Mol Ther; 2007 Oct; 9(5):447-66. PubMed ID: 17932809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-fighting viruses win approval.
    Ledford H
    Nature; 2015 Oct; 526(7575):622-3. PubMed ID: 26511559
    [No Abstract]   [Full Text] [Related]  

  • 10. Advance in herpes simplex viruses for cancer therapy.
    Liu S; Dai M; You L; Zhao Y
    Sci China Life Sci; 2013 Apr; 56(4):298-305. PubMed ID: 23564184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases.
    Kuroda T; Martuza RL; Todo T; Rabkin SD
    BMC Biotechnol; 2006 Sep; 6():40. PubMed ID: 16995942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles.
    Loskog A
    Viruses; 2015 Nov; 7(11):5780-91. PubMed ID: 26561829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic, immunological, and pharmacological strategies to generate improved oncolytic viruses].
    Pol J; Le Bœuf F; Diallo JS
    Med Sci (Paris); 2013 Feb; 29(2):165-73. PubMed ID: 23452603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant DNA virus vectors for vaccination.
    Moss B
    Semin Immunol; 1990 Sep; 2(5):317-27. PubMed ID: 2134016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Quest for Immunity: Exploring Human Herpesviruses as Vaccine Vectors.
    Kamel MS; Munds RA; Verma MS
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models.
    Terada K; Wakimoto H; Tyminski E; Chiocca EA; Saeki Y
    Gene Ther; 2006 Apr; 13(8):705-14. PubMed ID: 16421599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of hybrid viral vectors for gene therapy.
    Huang S; Kamihira M
    Biotechnol Adv; 2013; 31(2):208-23. PubMed ID: 23070017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli.
    Hoffmann D; Wildner O
    BMC Biotechnol; 2006 Aug; 6():36. PubMed ID: 16887042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viruses as tools in gene therapy, vaccine development, and cancer treatment.
    Bin Umair M; Akusa FN; Kashif H; Seerat-E-Fatima ; Butt F; Azhar M; Munir I; Ahmed M; Khalil W; Sharyar H; Rafique S; Shahid M; Afzal S
    Arch Virol; 2022 Jun; 167(6):1387-1404. PubMed ID: 35462594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in cloning herpesviral genomes as infectious bacterial artificial chromosomes.
    Zhou F; Gao SJ
    Cell Cycle; 2011 Feb; 10(3):434-40. PubMed ID: 21245660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.